Molecular Vision 2013; 19:1258-1258 <http://www.molvis.org/molvis/v19/1258>
Received 07 March 2013 | Accepted 19 March 2013 | Published 06 June 2013

This Article

Download PDF

Citation (for Endnote)

Google Scholar

Articles by the Authors

Withdrawal: Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells

The Editors of Molecular Vision

Correspondence to: Molecular Vision, email: molvis@emory.edu

Due to duplicate publication of part of Figure 1c from [1] in Figure 5 of [2], the authors of [2] have voluntarily withdrawn their article from Molecular Vision. The corresponding author of [2] was the first to bring this error to the attention of the Editors. He did so promptly, and it was he who first sought to withdraw the article.

References

  1. Acharya S, Dilnawaz F, Sahoo SK. Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. Biomaterials. 2009; 30:5737-50. [PMID: 19631377]
  2. Mitra M, Misra R, Harilal A, Sahoo SK, Krishnakumar S. Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells. Mol Vis. 2011; 17:2724-37.Epub 2011 Oct 19 [PMID: 22065926]